For research use only. Not for therapeutic Use.
Gepirone-d8 (CAS: 2749331-28-8), a premium pharmaceutical research compound designed for advanced anxiolytic and antidepressant studies. As a deuterated analog of Gepirone, it offers enhanced stability and improved pharmacokinetic properties. Gepirone-d8 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel anxiety and depression therapies. Trusted by leading laboratories, Gepirone-d8 is your go-to solution for cutting-edge mental health research. Unlock new possibilities in anxiety and depression treatment with Gepirone-d8, where innovation meets reliability.
| Catalog Number | S000249 |
| CAS Number | 2749331-28-8 |
| Molecular Formula | C19H21D8N5O2 |
| Purity | ≥95% |
| IUPAC Name | 4,4-dimethyl-1-[4-(2,2,3,3,5,5,6,6-octadeuterio-4-pyrimidin-2-ylpiperazin-1-yl)butyl]piperidine-2,6-dione |
| InChI | InChI=1S/C19H29N5O2/c1-19(2)14-16(25)24(17(26)15-19)9-4-3-8-22-10-12-23(13-11-22)18-20-6-5-7-21-18/h5-7H,3-4,8-15H2,1-2H3/i10D2,11D2,12D2,13D2 |
| InChIKey | QOIGKGMMAGJZNZ-BGKXKQMNSA-N |
| SMILES | [2H]C1(C(N(C(C(N1CCCCN2C(=O)CC(CC2=O)(C)C)([2H])[2H])([2H])[2H])C3=NC=CC=N3)([2H])[2H])[2H] |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. |
